510(k) K822663
K822663 is an FDA 510(k) premarket notification submitted by Oxoid U.S.A., Inc. for the device "FEBRILE ANTIGEN KIT". The FDA issued a decision of Substantially Equivalent on September 21, 1982. The device falls under product code GSO (Antigens (Febrile), Agglutination, Brucella Spp.), a Class II device regulated under 21 CFR 866.3085. Oxoid U.S.A., Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 21, 1982
- Date Received
- September 3, 1982
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigens (Febrile), Agglutination, Brucella Spp.
- Device Class
- Class II
- Regulation Number
- 866.3085
- Review Panel
- MI
- Submission Type